ImmuCell CorporationICCCNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+14.4%
5Y CAGR+10.8%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+14.4%/yr
vs +10.2%/yr prior
5Y CAGR
+10.8%/yr
Recent acceleration
Acceleration
+4.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$11.44M+44.1%
2024$7.94M+80.6%
2023$4.40M-42.5%
2022$7.65M-11.6%
2021$8.66M+26.1%
2020$6.86M+1.8%
2019$6.74M+29.8%
2018$5.19M-0.5%
2017$5.22M-3.7%
2016$5.42M-